Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Pain Management

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1110270

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1110270

Europe Medical Cannabis Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 306 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

The Europe medical cannabis market is projected to register a substantial CAGR of 29.5% , in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.

Market Segmentation:

Europe Medical Cannabis Market, By Product (Oil, Dried Medial Cannabis, Medical Cannabis Capsules, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer And Others), Source (synthetic And Natural), Species (Cannabis Indica, Sativa And Hybrid ), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), And Others), (Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease/Migranes, Epilepsy, Depression And Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood And Others. ), Route of Administration (Oral Solutions And Capsules, Smoking, Vaporizers, Topicals And Others) (End User (Pharmaceutical Industry, Research And Development Centers, Homecare Settings, Hospital And Rehab Centers And Others.), Distribution Channel (B2B and B2C), Country (Germany, U.K., Ital, Netherlands, Switzerland, France, Russia, Spain, Belgium and Rest of Europe) Industry Trends & Forecast To 2029.

Some of the major factors contributing to the growth of the Europe medical cannabismarket are:

  • The rise in good manufacturing practice certifications, legalization of medical cannabis and rise in elderly population in Europe
  • Use of medical cannabis in cosmetic industry in Europe

Market Players:

Some of the major players operating in the market are:

  • Tilray
  • Medipharm Labs
  • Althea Company Pty Ltd
  • PharmaHemp
  • Aurora Cannabis
  • Elixinol Wellness Limited
  • CANOPY GROWTH CORPORATION
  • Jazz Pharmaceuticals, Inc.
  • ECOGEN BIOSCIENCES
  • Little Green Pharma
  • GRASS & CO.,
  • CANNARAY
  • Sanity Group GmbH.
  • VIVO Cannabis Inc.
  • HEXO Corp.
  • Marrican Inc
Show more

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF THE EUROPE MEDICAL CANNABIS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCT LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET END USER COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PORTER'S FIVE FORCES
  • 4.2 PESTEL ANALYSIS
  • 4.3 EUROPE MEDICAL CANNABIS MARKET: AVAILABLE PRODUCTS WITH PRICES
  • 4.4 EUROPE MEDICAL CANNABIS MARKET: NUMBER OF PATIENTS AND FORECAST (2020-2029)

5 EUROPE MEDICAL CANNABIS MARKET: REGULATIONS

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 RISE IN GERIATRIC POPULATION
    • 6.1.2 RISE IN INCIDENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS
    • 6.1.3 LEGALIZATION OF CANNABIS
    • 6.1.4 INCREASED USAGE OF CANNABIS SEEDS IN COSMETIC PRODUCTS
    • 6.1.5 FUNCTIONAL PROPERTIES OF CANNABIS AND THEIR INCREASED USE IN DIFFERENT INDUSTRIES
  • 6.2 RESTRAINTS
    • 6.2.1 LONG TERM AND SHORT TERM SIDE EFFECTS RELATED TO THE USE OF CANNABIS AND CANNABIS OVERUSE
    • 6.2.2 HIGH COST
    • 6.2.3 ETHICAL ISSUES RELATED TO THE USE OF MEDICAL CANNABIS
    • 6.2.4 COMPLEX REGULATORY STRUCTURE FOR USAGE OF CANNABIS
  • 6.3 OPPORTUNITIES
    • 6.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING RESEARCH AND DEVELOPMENT (R & D) ACTIVITIES
    • 6.3.2 INCREASED MEDICINAL USE OF MEDICAL CANNABIS
    • 6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
  • 6.4 CHALLENGES
    • 6.4.1 SHORTAGE OF SKILLED PERSONNEL
    • 6.4.2 RISE OF THE MARIJUANA BLACK MARKET

7 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT

  • 7.1 OVERVIEW
  • 7.2 OIL
    • 7.2.1 BY TYPE
      • 7.2.1.1 CBD OIL CONCENTRATES
      • 7.2.1.2 CBD VAPE OIL
      • 7.2.1.3 CBD TINCTURES
    • 7.2.2 BY SOURCE
      • 7.2.2.1 HEMP BASED
      • 7.2.2.2 MARIJUANA BASED
    • 7.2.3 BY SPECIES
      • 7.2.3.1 SATIVA
      • 7.2.3.2 HYBRID
      • 7.2.3.3 CANNABIS-INDICA
  • 7.3 DRIED MEDICAL CANNABIS
    • 7.3.1 BY SPECIES
      • 7.3.1.1 CANNABIS INDICA
      • 7.3.1.2 SATIVA
      • 7.3.1.3 HYBRID
  • 7.4 MEDICAL CANNABIS CAPSULES
    • 7.4.1 BY TYPE
      • 7.4.1.1 OIL BASED CANNABIS CAPSULES
      • 7.4.1.2 POWDER BASED CANNABIS CAPSULES
      • 7.4.1.3 OTHERS
    • 7.4.2 BY SOURCE
      • 7.4.2.1 HIGH CBD CAPSULES
      • 7.4.2.2 HIGH THC CAPSULE
      • 7.4.2.3 THC/CBD BALANCED CAPSULE
      • 7.4.2.4 CBD ISOLATE CAPSULE
    • 7.4.3 BY SPECIES
      • 7.4.3.1 SATIVA
      • 7.4.3.2 HYBRID
      • 7.4.3.3 CANNABIS-INDICA
  • 7.5 VAPE PEN
    • 7.5.1 BY SPECIES
      • 7.5.1.1 SATIVA
      • 7.5.1.2 HYBRID
      • 7.5.1.3 CANNABIS-INDICA
  • 7.6 WHOLE FLOWER
    • 7.6.1 BY SPECIES
      • 7.6.1.1 SATIVA
      • 7.6.1.2 HYBRID
      • 7.6.1.3 CANNABIS-INDICA
  • 7.7 CREAMS AND MOISTURIZERS
  • 7.8 GROUND FLOWER
    • 7.8.1 BY SPECIES
      • 7.8.1.1 CANNABIS-INDICA
      • 7.8.1.2 SATIVA
      • 7.8.1.3 HYBRID
  • 7.9 OTHERS

8 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE

  • 8.1 OVERVIEW
  • 8.2 NATURAL
  • 8.3 SYNTHETIC
    • 8.3.1 DRONABINOL
    • 8.3.2 NABILONE

9 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES

  • 9.1 OVERVIEW
  • 9.2 SATIVA
  • 9.3 HYBRID
  • 9.4 CANNABIS INDICA

10 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES

  • 10.1 OVERVIEW
  • 10.2 CANNABIDIOL (CBD)
  • 10.3 TETRAHYDROCANNABINOL(THC)/DELTA-8-TETRAHYDROCANNABINOL
  • 10.4 OTHERS

11 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION

  • 11.1 OVERVIEW
  • 11.2 PAIN MANAGEMENT
    • 11.2.1 BY TYPE
      • 11.2.1.1 CHRONIC PAIN
      • 11.2.1.2 NEUROLOGICAL PAIN
    • 11.2.2 BY PRODUCT
      • 11.2.2.1 OIL
      • 11.2.2.2 MEDICAL CANNABIS CAPSULES
      • 11.2.2.3 DRIED MEDICAL CANNABIS
      • 11.2.2.4 GROUND FLOWER
      • 11.2.2.5 CREAMS & MOISTURIZER
      • 11.2.2.6 VAPE PEN
      • 11.2.2.7 WHOLE FLOWER
      • 11.2.2.8 OTHERS
  • 11.3 ANXIETY
    • 11.3.1 OIL
    • 11.3.2 MEDICAL CANNABIS CAPSULES
    • 11.3.3 DRIED MEDICAL CANNABIS
    • 11.3.4 GROUND FLOWER
    • 11.3.5 VAPE PEN
    • 11.3.6 WHOLE FLOWER
    • 11.3.7 OTHERS
  • 11.4 MUSCLE SPASMS
    • 11.4.1 OIL
    • 11.4.2 MEDICAL CANNABIS CAPSULES
    • 11.4.3 DRIED MEDICAL CANNABIS
    • 11.4.4 CREAMS & MOISTURIZER
    • 11.4.5 GROUND FLOWER
    • 11.4.6 VAPE PEN
    • 11.4.7 WHOLE FLOWER
    • 11.4.8 OTHERS
  • 11.5 NAUSEA
    • 11.5.1 OIL
    • 11.5.2 MEDICAL CANNABIS CAPSULES
    • 11.5.3 DRIED MEDICAL CANNABIS
    • 11.5.4 CREAMS & MOISTURIZER
    • 11.5.5 GROUND FLOWER
    • 11.5.6 VAPE PEN
    • 11.5.7 WHOLE FLOWER
    • 11.5.8 OTHERS
  • 11.6 APPETITE LOSS
    • 11.6.1 OIL
    • 11.6.2 MEDICAL CANNABIS CAPSULES
    • 11.6.3 DRIED MEDICAL CANNABIS
    • 11.6.4 GROUND FLOWER
    • 11.6.5 WHOLE FLOWER
    • 11.6.6 VAPE PEN
    • 11.6.7 OTHERS
  • 11.7 CANCER
    • 11.7.1 OIL
    • 11.7.2 MEDICAL CANNABIS CAPSULES
    • 11.7.3 DRIED MEDICAL CANNABIS
    • 11.7.4 GROUND FLOWER
    • 11.7.5 VAPE PEN
    • 11.7.6 WHOLE FLOWER
    • 11.7.7 OTHERS
  • 11.8 ARTHRITIS
    • 11.8.1 OIL
    • 11.8.2 MEDICAL CANNABIS CAPSULES
    • 11.8.3 DRIED MEDICAL CANNABIS
    • 11.8.4 GROUND FLOWER
    • 11.8.5 CREAMS AND MOISTURIZER
    • 11.8.6 WHOLE FLOWER
    • 11.8.7 VAPE PEN
    • 11.8.8 OTHERS
  • 11.9 ALZHEIMER'S DISEASE/MIGRAINES
    • 11.9.1 OIL
    • 11.9.2 DRIED MEDICAL CANNABIS
    • 11.9.3 MEDICAL CANNABIS CAPSULES
    • 11.9.4 GROUND FLOWER
    • 11.9.5 VAPE PEN
    • 11.9.6 WHOLE FLOWER
    • 11.9.7 OTHERS
  • 11.10 EPILEPSY
    • 11.10.1 .OIL
    • 11.10.2 MEDICAL CANNABIS CAPSULES
    • 11.10.3 OTHERS
  • 11.11 DEPRESSION AND SLEEP DISORDERS
    • 11.11.1 OIL
    • 11.11.2 DRIED MEDICAL CANNABIS
    • 11.11.3 MEDICAL CANNABIS CAPSULES
    • 11.11.4 OTHERS
  • 11.12 MULTIPLE SCLEROSIS
    • 11.12.1 OIL
    • 11.12.2 DRIED MEDICAL CANNABIS
    • 11.12.3 MEDICAL CANNABIS CAPSULES
    • 11.12.4 GROUND FLOWER
    • 11.12.5 VAPE PEN
    • 11.12.6 WHOLE FLOWER
    • 11.12.7 OTHERS
  • 11.13 AUTISM
    • 11.13.1 OIL
    • 11.13.2 MEDICAL CANNABIS CAPSULES
    • 11.13.3 OTHERS
  • 11.14 MENTAL HEALTH CONDITIONS
    • 11.14.1 BY TYPE
      • 11.14.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)
      • 11.14.1.2 SCHIZOPHRENIA
      • 11.14.1.3 OTHERS
    • 11.14.2 BY PRODUCT
      • 11.14.2.1 OIL
      • 11.14.2.2 MEDICAL CANNABIS CAPSULES
      • 11.14.2.3 OTHERS
  • 11.15 ELEVATE MOOD
    • 11.15.1 OIL
    • 11.15.2 DRIED MEDICAL CANNABIS
    • 11.15.3 MEDICAL CANNABIS CAPSULES
    • 11.15.4 OTHERS
  • 11.16 OTHERS

12 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

  • 12.1 OVERVIEW
  • 12.2 ORAL SOLUTION AND CAPSULES
  • 12.3 SMOKING
  • 12.4 TOPICALS
  • 12.5 VAPORIZERS
  • 12.6 OTHERS

13 EUROPE MEDICAL CANNABIS MARKET, BY END USER

  • 13.1 OVERVIEW
  • 13.2 HOMECARE SETTING
  • 13.3 HOSPITAL
  • 13.4 REHAB CENTERS
  • 13.5 PHARMACEUTICAL INDUSTRY
  • 13.6 RESEARCH AND DEVELOPMENT CENTERS
  • 13.7 OTHERS

14 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

  • 14.1 OVERVIEW
  • 14.2 B2C
    • 14.2.1 ONLINE STORES
    • 14.2.2 PHARMACIES
    • 14.2.3 CONVENTIONAL STORES
    • 14.2.4 OTHERS
  • 14.3 B2B

15 EUROPE MEDICAL CANNABIS MARKET BY REGION

  • 15.1 EUROPE
    • 15.1.1 GERMANY
    • 15.1.2 U.K.
    • 15.1.3 ITALY
    • 15.1.4 ETHERLANDS
    • 15.1.5 SWITZERLAND
    • 15.1.6 FRANCE
    • 15.1.7 RUSSIA
    • 15.1.8 SPAIN
    • 15.1.9 BELGIUM
    • 15.1.10 REST OF EUROPE

16 EUROPE MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE

  • 16.1 COMPANY SHARE ANALYSIS: EUROPE

17 SWOT ANALYSIS

18 COMPANY PROFILE

  • 18.1 TILRAY (2021)
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 PRODUCT PORTFOLIO
    • 18.1.4 RECENT DEVELOPMENTS
  • 18.2 JAZZ PHARMACEUTICALS PLC (2021)
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 PRODUCT PORTFOLIO
    • 18.2.4 RECENT DEVELOPMENT
  • 18.3 AURORA CANNABIS INC. (2021)
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 PRODUCT PORTFOLIO
    • 18.3.4 RECENT DEVELOPMENTS
  • 18.4 SANITY GROUP GMBH (2021)
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 PRODUCT PORTFOLIO
    • 18.4.3 RECENT DEVELOPMENT
  • 18.5 CANNARAY (2021)
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 PRODUCT PORTFOLIO
    • 18.5.3 RECENT DEVELOPMENTS
  • 18.6 ALTHEA COMPANY PTY LTD (A SUBSIDIARY OF ALTHEA GROUP HOLDINGS LIMITED) (2021)
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 REVENUE ANALYSIS
    • 18.6.3 PRODUCT PORTFOLIO
    • 18.6.4 RECENT DEVELOPMENTS
  • 18.7 CANOPY GROWTH CORPORATION (2021)
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 REVENUE ANALYSIS
    • 18.7.3 PRODUCT PORTFOLIO
    • 18.7.4 RECENT DEVELOPMENTS
  • 18.8 ECOGEN BIOSCIENCES (2021)
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 PRODUCT PORTFOLIO
    • 18.8.3 RECENT DEVELOPMENTS
  • 18.9 ELIXINOL WELLNESS LIMITED (2021)
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 REVENUE ANALYSIS
    • 18.9.3 PRODUCT PORTFOLIO
    • 18.9.4 RECENT DEVELOPMENTS
  • 18.10 GRASS & CO. (2021)
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 PRODUCT PORTFOLIO
    • 18.10.3 RECENT DEVELOPMENTS
  • 18.11 HEXO CORP (2021)
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 REVENUE ANALYSIS
    • 18.11.3 PRODUCT PORTFOLIO
    • 18.11.4 RECENT DEVELOPMENT
  • 18.12 LITTLE GREEN PHARMA (2021)
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 REVENUE ANALYSIS
    • 18.12.3 PRODUCT PORTFOLIO
    • 18.12.4 RECENT DEVELOPMENTS
  • 18.13 MEDIPHARM LABS INC (2021)
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 REVENUE ANALYSIS
    • 18.13.3 PRODUCT PORTFOLIO
    • 18.13.4 RECENT DEVELOPMENTS
  • 18.14 MARICAN INC.
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 PRODUCT PORTFOLIO
    • 18.14.3 RECENT DEVELOPMENTS
  • 18.15 PHARMA HEMP (2021)
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 PRODUCT PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENTS
  • 18.16 VIVO CANNABIS INC. (2021)
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 PRODUCT PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

Show more

LIST OF TABLES

  • TABLE 1 EUROPE MEDICAL CANNABIS MARKET, BY NUMBER OF PATIENTS, 2020-2029 (IN NUMBER) 58
  • TABLE 2 NEUROLOGICAL CONDITIONS FOR WHICH CANNABIS-BASED TREATMENTS HAVE BEEN EMPLOYED 75
  • TABLE 3 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 80
  • TABLE 4 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 81
  • TABLE 5 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 82
  • TABLE 6 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 82
  • TABLE 7 EUROPE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 83
  • TABLE 8 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 85
  • TABLE 9 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 85
  • TABLE 10 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 86
  • TABLE 11 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 87
  • TABLE 12 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 88
  • TABLE 13 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 90
  • TABLE 18 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 114
  • TABLE 19 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 115
  • TABLE 20 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 116
  • TABLE 21 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 118
  • TABLE 22 EUROPE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 119
  • TABLE 23 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 120
  • TABLE 24 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 122
  • TABLE 25 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 124
  • TABLE 26 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 125
  • TABLE 27 EUROPE ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 127
  • TABLE 28 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 128
  • TABLE 29 EUROPE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 129
  • TABLE 30 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 130
  • TABLE 31 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 132
  • TABLE 32 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 33 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 133
  • TABLE 34 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 134
  • TABLE 35 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 139
  • TABLE 36 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 145
  • TABLE 37 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 152
  • TABLE 38 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 153
  • TABLE 39 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 160
  • TABLE 40 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 161
  • TABLE 41 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 161
  • TABLE 42 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 161
  • TABLE 43 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 162
  • TABLE 44 GERMANY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 162
  • TABLE 45 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 162
  • TABLE 46 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 162
  • TABLE 47 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 162
  • TABLE 48 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 163
  • TABLE 49 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 163
  • TABLE 50 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 163
  • TABLE 51 GERMANY MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 164
  • TABLE 52 GERMANY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 53 GERMANY MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 164
  • TABLE 54 GERMANY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 164
  • TABLE 55 GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 165
  • TABLE 56 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 165
  • TABLE 57 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 166
  • TABLE 58 GERMANY ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 166
  • TABLE 59 GERMANY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 167
  • TABLE 60 GERMANY NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 167
  • TABLE 61 GERMANY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 168
  • TABLE 62 GERMANY CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 168
  • TABLE 63 GERMANY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 169
  • TABLE 64 GERMANY ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 169
  • TABLE 65 GERMANY EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 169
  • TABLE 66 GERMANY DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 170
  • TABLE 67 GERMANY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 170
  • TABLE 68 GERMANY AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 170
  • TABLE 69 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 171
  • TABLE 70 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 171
  • TABLE 71 GERMANY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 171
  • TABLE 72 GERMANY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 171
  • TABLE 73 GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 172
  • TABLE 74 GERMANY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 172
  • TABLE 75 GERMANY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 172
  • TABLE 76 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 173
  • TABLE 77 U.K. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 173
  • TABLE 78 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 173
  • TABLE 79 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 174
  • TABLE 80 U.K. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 174
  • TABLE 81 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 82 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 174
  • TABLE 83 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 175
  • TABLE 84 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 175
  • TABLE 85 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 175
  • TABLE 86 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 175
  • TABLE 87 U.K. MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 176
  • TABLE 88 U.K. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 89 U.K. MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 176
  • TABLE 90 U.K. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 176
  • TABLE 91 U.K. MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 177
  • TABLE 92 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 177
  • TABLE 93 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 178
  • TABLE 94 U.K. ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 178
  • TABLE 95 U.K. MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 179
  • TABLE 96 U.K. NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 179
  • TABLE 97 U.K. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 180
  • TABLE 98 U.K. CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 180
  • TABLE 99 U.K. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 180
  • TABLE 100 U.K. ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 181
  • TABLE 101 U.K. EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 181
  • TABLE 102 U.K. DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 181
  • TABLE 103 U.K. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 182
  • TABLE 104 U.K. AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 182
  • TABLE 105 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 182
  • TABLE 106 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 183
  • TABLE 107 U.K. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 183
  • TABLE 108 U.K. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 183
  • TABLE 109 U.K. MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 184
  • TABLE 110 U.K. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 184
  • TABLE 111 U.K. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 184
  • TABLE 112 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 185
  • TABLE 113 ITALY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 185
  • TABLE 114 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 185
  • TABLE 115 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 186
  • TABLE 116 ITALY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 186
  • TABLE 117 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 186
  • TABLE 118 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 186
  • TABLE 119 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 187
  • TABLE 120 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 187
  • TABLE 121 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 187
  • TABLE 122 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 187
  • TABLE 123 ITALY MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 188
  • TABLE 124 ITALY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 188
  • TABLE 125 ITALY MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 188
  • TABLE 126 ITALY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 188
  • TABLE 127 ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 189
  • TABLE 128 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 189
  • TABLE 129 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 190
  • TABLE 130 ITALY ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 190
  • TABLE 131 ITALY MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 191
  • TABLE 132 ITALY NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 191
  • TABLE 133 ITALY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 192
  • TABLE 134 ITALY CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 192
  • TABLE 135 ITALY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 192
  • TABLE 136 ITALY ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 193
  • TABLE 137 ITALY EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 193
  • TABLE 138 ITALY DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 193
  • TABLE 139 ITALY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 194
  • TABLE 140 ITALY AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 194
  • TABLE 141 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 194
  • TABLE 142 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 195
  • TABLE 143 ITALY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 195
  • TABLE 144 ITALY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 195
  • TABLE 145 ITALY MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 196
  • TABLE 146 ITALY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 196
  • TABLE 147 ITALY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 196
  • TABLE 148 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 197
  • TABLE 149 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 197
  • TABLE 150 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 197
  • TABLE 151 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 198
  • TABLE 152 NETHERLANDS DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 198
  • TABLE 153 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 198
  • TABLE 154 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 198
  • TABLE 155 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 199
  • TABLE 156 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 199
  • TABLE 157 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 199
  • TABLE 158 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 199
  • TABLE 159 NETHERLANDS MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 200
  • TABLE 160 NETHERLANDS SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 200
  • TABLE 161 NETHERLANDS MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 200
  • TABLE 162 NETHERLANDS MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 200
  • TABLE 163 NETHERLANDS MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 201
  • TABLE 164 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 201
  • TABLE 165 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 202
  • TABLE 166 NETHERLANDS ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 202
  • TABLE 167 NETHERLANDS MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 203
  • TABLE 168 NETHERLANDS NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 203
  • TABLE 169 NETHERLANDS APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 204
  • TABLE 170 NETHERLANDS CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 204
  • TABLE 171 NETHERLANDS ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 205
  • TABLE 172 NETHERLANDS ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 205
  • TABLE 173 NETHERLANDS EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 205
  • TABLE 174 NETHERLANDS DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 206
  • TABLE 175 NETHERLANDS MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 206
  • TABLE 176 NETHERLANDS AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 206
  • TABLE 177 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 207
  • TABLE 178 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 207
  • TABLE 179 NETHERLANDS ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 207
  • TABLE 180 NETHERLANDS MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 207
  • TABLE 181 NETHERLANDS MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 208
  • TABLE 182 NETHERLANDS MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 208
  • TABLE 183 NETHERLANDS B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 208
  • TABLE 184 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 209
  • TABLE 185 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 209
  • TABLE 186 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 209
  • TABLE 187 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 210
  • TABLE 188 SWITZERLAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 210
  • TABLE 189 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 210
  • TABLE 190 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 210
  • TABLE 191 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 211
  • TABLE 192 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 211
  • TABLE 193 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 211
  • TABLE 194 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 212
  • TABLE 195 SWITZERLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 212
  • TABLE 196 SWITZERLAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 212
  • TABLE 197 SWITZERLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 212
  • TABLE 198 SWITZERLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 213
  • TABLE 199 SWITZERLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 213
  • TABLE 200 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 213
  • TABLE 201 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 214
  • TABLE 202 SWITZERLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 214
  • TABLE 203 SWITZERLAND MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 215
  • TABLE 204 SWITZERLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 215
  • TABLE 205 SWITZERLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 216
  • TABLE 206 SWITZERLAND CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 216
  • TABLE 207 SWITZERLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 217
  • TABLE 208 SWITZERLAND ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 217
  • TABLE 209 SWITZERLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 217
  • TABLE 210 SWITZERLAND DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 218
  • TABLE 211 SWITZERLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 218
  • TABLE 212 SWITZERLAND AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 218
  • TABLE 213 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 219
  • TABLE 214 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 219
  • TABLE 215 SWITZERLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 219
  • TABLE 216 SWITZERLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 219
  • TABLE 217 SWITZERLAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 220
  • TABLE 218 SWITZERLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 220
  • TABLE 219 SWITZERLAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 220
  • TABLE 220 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 221
  • TABLE 221 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 221
  • TABLE 222 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 221
  • TABLE 223 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 222
  • TABLE 224 FRANCE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 222
  • TABLE 225 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 222
  • TABLE 226 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 222
  • TABLE 227 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 223
  • TABLE 228 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 223
  • TABLE 229 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 223
  • TABLE 230 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 223
  • TABLE 231 FRANCE MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 224
  • TABLE 232 FRANCE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 224
  • TABLE 233 FRANCE MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 224
  • TABLE 234 FRANCE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 224
  • TABLE 235 FRANCE MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 225
  • TABLE 236 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 225
  • TABLE 237 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 226
  • TABLE 238 FRANCE ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 226
  • TABLE 239 FRANCE MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 227
  • TABLE 240 FRANCE NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 227
  • TABLE 241 FRANCE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 228
  • TABLE 242 FRANCE CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 228
  • TABLE 243 FRANCE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 229
  • TABLE 244 FRANCE ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 229
  • TABLE 245 FRANCE EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 229
  • TABLE 246 FRANCE DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 230
  • TABLE 247 FRANCE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 230
  • TABLE 248 FRANCE AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 230
  • TABLE 249 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 231
  • TABLE 250 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 231
  • TABLE 251 FRANCE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 231
  • TABLE 252 FRANCE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 231
  • TABLE 253 FRANCE MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 232
  • TABLE 254 FRANCE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 232
  • TABLE 255 FRANCE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 232
  • TABLE 256 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 233
  • TABLE 257 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 233
  • TABLE 258 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 233
  • TABLE 259 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 234
  • TABLE 260 RUSSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 234
  • TABLE 261 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 234
  • TABLE 262 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 234
  • TABLE 263 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 235
  • TABLE 264 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 235
  • TABLE 265 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 235
  • TABLE 266 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 235
  • TABLE 267 RUSSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 236
  • TABLE 268 RUSSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 236
  • TABLE 269 RUSSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 236
  • TABLE 270 RUSSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 236
  • TABLE 271 RUSSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 237
  • TABLE 272 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 237
  • TABLE 273 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 238
  • TABLE 274 RUSSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 238
  • TABLE 275 RUSSIA MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 239
  • TABLE 276 RUSSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 239
  • TABLE 277 RUSSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 240
  • TABLE 278 RUSSIA CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 240
  • TABLE 279 RUSSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 241
  • TABLE 280 RUSSIA ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 241
  • TABLE 281 RUSSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 241
  • TABLE 282 RUSSIA DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 242
  • TABLE 283 RUSSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 242
  • TABLE 284 RUSSIA AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 242
  • TABLE 285 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 243
  • TABLE 286 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 243
  • TABLE 287 RUSSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 243
  • TABLE 288 RUSSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 243
  • TABLE 289 RUSSIA MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 244
  • TABLE 290 RUSSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 244
  • TABLE 291 RUSSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 244
  • TABLE 292 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 245
  • TABLE 293 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 245
  • TABLE 294 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 245
  • TABLE 295 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 246
  • TABLE 296 SPAIN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 246
  • TABLE 297 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 246
  • TABLE 298 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 246
  • TABLE 299 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 247
  • TABLE 300 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 247
  • TABLE 301 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 247
  • TABLE 302 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 247
  • TABLE 303 SPAIN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 248
  • TABLE 304 SPAIN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 248
  • TABLE 305 SPAIN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 248
  • TABLE 306 SPAIN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 248
  • TABLE 307 SPAIN MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 249
  • TABLE 308 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 249
  • TABLE 309 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 250
  • TABLE 310 SPAIN ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 250
  • TABLE 311 SPAIN MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 251
  • TABLE 312 SPAIN NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 251
  • TABLE 313 SPAIN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 252
  • TABLE 314 SPAIN CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 252
  • TABLE 315 SPAIN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 253
  • TABLE 316 SPAIN ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 253
  • TABLE 317 SPAIN EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 253
  • TABLE 318 SPAIN DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 254
  • TABLE 319 SPAIN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 254
  • TABLE 320 SPAIN AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 254
  • TABLE 321 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 255
  • TABLE 322 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 255
  • TABLE 323 SPAIN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 255
  • TABLE 324 SPAIN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 255
  • TABLE 325 SPAIN MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 256
  • TABLE 326 SPAIN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 256
  • TABLE 327 SPAIN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 256
  • TABLE 328 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 257
  • TABLE 329 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 257
  • TABLE 330 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 257
  • TABLE 331 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 258
  • TABLE 332 BELGIUM DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 258
  • TABLE 333 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 258
  • TABLE 334 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2020-2029 (USD MILLION) 258
  • TABLE 335 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 259
  • TABLE 336 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 259
  • TABLE 337 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 259
  • TABLE 338 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 259
  • TABLE 339 BELGIUM MEDICAL CANNABIS MARKET, BY SOURCE, 2020-2029 (USD MILLION) 260
  • TABLE 340 BELGIUM SYNTHETIC IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 260
  • TABLE 341 BELGIUM MEDICAL CANNABIS MARKET, BY SPECIES, 2020-2029 (USD MILLION) 260
  • TABLE 342 BELGIUM MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2020-2029 (USD MILLION) 260
  • TABLE 343 BELGIUM MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION) 261
  • TABLE 344 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 261
  • TABLE 345 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 262
  • TABLE 346 BELGIUM ANXIETY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 262
  • TABLE 347 BELGIUM MUSCLE SPASMS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 263
  • TABLE 348 BELGIUM NAUSEA IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 263
  • TABLE 349 BELGIUM APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 264
  • TABLE 350 BELGIUM CANCER IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 264
  • TABLE 351 BELGIUM ARTHRITIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 265
  • TABLE 352 BELGIUM ALZHEIMER'S DISEASE/MIGRAINES IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 265
  • TABLE 353 BELGIUM EPILEPSY IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 265
  • TABLE 354 BELGIUM DEPRESSION AND SLEEP DISORDERS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 266
  • TABLE 355 BELGIUM MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 266
  • TABLE 356 BELGIUM AUTISM IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 266
  • TABLE 357 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2020-2029 (USD MILLION) 267
  • TABLE 358 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 267
  • TABLE 359 BELGIUM ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 267
  • TABLE 360 BELGIUM MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION) 268
  • TABLE 361 BELGIUM MEDICAL CANNABIS MARKET, BY END USER, 2020-2029 (USD MILLION) 268
  • TABLE 362 BELGIUM MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 268
  • TABLE 363 BELGIUM B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 269
  • TABLE 364 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2020-2029 (USD MILLION) 270

LIST OF FIGURES

  • FIGURE 1 EUROPE MEDICAL CANNABIS MARKET: SEGMENTATION 39
  • FIGURE 2 EUROPE MEDICAL CANNABIS MARKET: DATA TRIANGULATION 41
  • FIGURE 3 EUROPE MEDICAL CANNABIS MARKET: DROC ANALYSIS 42
  • FIGURE 4 EUROPE MEDICAL CANNABIS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 43
  • FIGURE 5 EUROPE MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS 43
  • FIGURE 6 EUROPE MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS 45
  • FIGURE 7 EUROPE MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID 46
  • FIGURE 8 EUROPE MEDICAL CANNABIS MARKET: END USER COVERAGE GRID 47
  • FIGURE 9 EUROPE MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS 48
  • FIGURE 10 EUROPE MEDICAL CANNABIS MARKET: SEGMENTATION 52
  • FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF THE MEDICAL CANNABIS MARKET ARE EXPECTED TO DRIVE THE EUROPE MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 53
  • FIGURE 12 OIL SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MEDICAL CANNABIS MARKET IN 2022 & 2029 53
  • FIGURE 13 EUROPE MEDICAL CANNABIS MARKET , NUMBER OF PATIENTS (2021) 59
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE MEDICAL CANNABIS MARKET 67
  • FIGURE 15 INCIDENCE OF EPILEPSY IN EUROPE COUNTRIES 69
  • FIGURE 16 EUROPE MEDICAL CANNABIS MARKET: BY PRODUCT, 2021 78
  • FIGURE 17 EUROPE MEDICAL CANNABIS MARKET: BY PRODUCT, 2022-2029 (USD MILLION) 79
  • FIGURE 18 EUROPE MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2022-2029) 79
  • FIGURE 19 EUROPE MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE 80
  • FIGURE 20 EUROPE MEDICAL CANNABIS MARKET: BY SOURCE, 2021 92
  • FIGURE 21 EUROPE MEDICAL CANNABIS MARKET: BY SOURCE, 2022-2029 (USD MILLION) 93
  • FIGURE 22 EUROPE MEDICAL CANNABIS MARKET: BY SOURCE, CAGR (2022-2029) 93
  • FIGURE 23 EUROPE MEDICAL CANNABIS MARKET: BY SOURCE, LIFELINE CURVE 94
  • FIGURE 24 EUROPE MEDICAL CANNABIS MARKET: BY SPECIES, 2021 98
  • FIGURE 25 EUROPE MEDICAL CANNABIS MARKET: BY SPECIES, 2022-2029 (USD MILLION) 99
  • FIGURE 26 EUROPE MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2022-2029) 99
  • FIGURE 27 EUROPE MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE 100
  • FIGURE 28 EUROPE MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2021 104
  • FIGURE 29 EUROPE MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022-2029 (USD MILLION) 105
  • FIGURE 30 EUROPE MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2022-2029) 105
  • FIGURE 31 EUROPE MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE 106
  • FIGURE 32 EUROPE MEDICAL CANNABIS MARKET: BY APPLICATION, 2021 111
  • FIGURE 33 EUROPE MEDICAL CANNABIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION) 112
  • FIGURE 34 EUROPE MEDICAL CANNABIS MARKET: BY APPLICATION, CAGR (2022-2029) 113
  • FIGURE 35 EUROPE MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE 114
  • FIGURE 36 EUROPE MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2021 137
  • FIGURE 37 EUROPE MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION) 138
  • FIGURE 38 EUROPE MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029) 138
  • FIGURE 39 EUROPE MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE 139
  • FIGURE 40 EUROPE MEDICAL CANNABIS MARKET: BY END USER, 2021 143
  • FIGURE 41 EUROPE MEDICAL CANNABIS MARKET: BY END USER, 2022-2029 (USD MILLION) 144
  • FIGURE 42 EUROPE MEDICAL CANNABIS MARKET: BY END USER, CAGR (2022-2029) 144
  • FIGURE 43 EUROPE MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE 145
  • FIGURE 44 EUROPE MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2021 150
  • FIGURE 45 EUROPE MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 151
  • FIGURE 46 EUROPE MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 151
  • FIGURE 47 EUROPE MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 152
  • FIGURE 48 EUROPE MEDICAL CANNABIS MARKET: SNAPSHOT (2021) 156
  • FIGURE 49 EUROPE MEDICAL CANNABIS MARKET: BY COUNTRY (2021) 158
  • FIGURE 50 EUROPE MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2029) 158
  • FIGURE 51 EUROPE MEDICAL CANNABIS MARKET: BY COUNTRY (2021 & 2029) 159
  • FIGURE 52 EUROPE MEDICAL CANNABIS MARKET: BY PRODUCT (2022 & 2029) 159
  • FIGURE 53 EUROPE MEDICAL CANNABIS MARKET: COMPANY SHARE 2021 (%) 271
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!